Shockwave IVL Maintains Superiority to Angioplasty in Calcified Peripheral Disease at Two Years
ShockWave Medical, Inc. (SWAV)
Last shockwave medical, inc. earnings: 2/13 04:03 pm
Check Earnings Report
Company Research
Source: GlobeNewswire
SANTA CLARA, Calif., May 19, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced today that long-term data from the Disrupt PAD III trial found that superior vessel preparation with IVL led to excellent long-term outcomes out to two years with preservation of future treatment options compared to percutaneous transluminal angioplasty (PTA) in the treatment of calcified peripheral artery disease. The final outcomes of the largest randomized trial of severely calcified peripheral lesions were presented by investigators today in a featured clinical research session at the 2022 Scientific Sessions of the Society for Cardiovascular Angiography & Interventions (SCAI) and published simultaneously in JSCAI. As previously published, IVL at 30 days demonstrated superiority over PTA in the primary endpoint analysis, defined as procedural success with a resi
Show less
Read more
Impact Snapshot
Event Time:
SWAV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SWAV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SWAV alerts
High impacting ShockWave Medical, Inc. news events
Weekly update
A roundup of the hottest topics
SWAV
News
- Why the Market Dipped But Shockwave Medical (SWAV) Gained Today [Yahoo! Finance]Yahoo! Finance
- Is Invesco S&P MidCap 400 GARP ETF (GRPM) a Strong ETF Right Now? [Yahoo! Finance]Yahoo! Finance
- Shockwave Medical (SWAV) Rose on an Acquisition News and Solid Financial Result [Yahoo! Finance]Yahoo! Finance
- Baron Health Care Fund Q1 2024 Shareholder Letter [Seeking Alpha]Seeking Alpha
- Why Investors Need to Take Advantage of These 2 Medical Stocks Now [Yahoo! Finance]Yahoo! Finance
SWAV
Earnings
- 2/15/24 - Beat
SWAV
Sec Filings
- 4/18/24 - Form PREM14A
- 4/9/24 - Form 8-K
- 4/5/24 - Form DFAN14A
- SWAV's page on the SEC website